Abbvie, 30 million investment on the Aprilia site


Thirty million euros of investments, only in 2019, for the production center of Campoverde di Aprilia (Latina). In total, over the past few years, total spending has reached the sum of 130 million euros. This as much as theAbbvie pharmaceutical company has fielded for its production center in the agro pontino, established in 1963 and which includes a formulation and packaging plant for finished products, two chemical plants, quality and innovation and development laboratories.

"In a context where resources are scarce and the economic situation is not favorable, AbbVie, as a global biopharmaceutical company, renews its commitment with an important and growing contribution in terms of innovation, investment, export, employment and research for the benefit of patients and the sustainability of the health system ", explains Fabrizio Greco, managing director of Abbvie Italy, during the meeting" The value of innovation for sustainable growth in the Campoverde plant. The Lazio plant exports more than 80% of its production and was the scene of a "green" turnaround. It has had a reduction of more than 50% in the use of groundwater, self-produces about 90% of its energy needs, sends zero waste to landfills and over 85% of its residues is destined for recycling.

"The Campoverde production site continuously uses resources with the aim of making the plant more efficient, competitive and sustainable," he says Daniela Toia, director of the AbbVie Italia production center – The expansion of the chemical plant and the new production lines, built according to the most advanced technologies, will support the production of our drugs based on the AbbVie Global strategic plan, including the new therapies for the treatment of autoimmune diseases, whose introduction on the market is expected in the coming months ".

Source link



Please enter your comment!
Please enter your name here

eleven + 19 =